Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 108

1.

Nasal osteoma and inhaled salmon calcitonin: Coincidence or consequence?

Peña-Rodríguez ZA, Haro-García M, Benito-Navarro JR.

Acta Otorrinolaringol Esp. 2017 Nov - Dec;68(6):366-368. doi: 10.1016/j.otorri.2016.09.004. Epub 2017 Jan 6. English, Spanish. No abstract available.

2.

A randomized, double-blind, multicenter, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of osteoporosis in postmenopausal women taking calcium and vitamin D.

Henriksen K, Byrjalsen I, Andersen JR, Bihlet AR, Russo LA, Alexandersen P, Valter I, Qvist P, Lau E, Riis BJ, Christiansen C, Karsdal MA; SMC021 investigators.

Bone. 2016 Oct;91:122-9. doi: 10.1016/j.bone.2016.07.019. Epub 2016 Jul 25.

PMID:
27462009
3.

[Seizure after salmon calcitonin administration: A case report].

Maison O, Pierre S, Charpiat B, Duplessy F, Vial T.

Therapie. 2016 Oct;71(5):529-531. doi: 10.1016/j.therap.2016.03.002. Epub 2016 May 4. French. No abstract available.

PMID:
27262670
4.

Does salmon calcitonin cause cancer? A review and meta-analysis.

Wells G, Chernoff J, Gilligan JP, Krause DS.

Osteoporos Int. 2016 Jan;27(1):13-9. doi: 10.1007/s00198-015-3339-z. Epub 2015 Oct 5. Review.

5.

Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials.

Karsdal MA, Byrjalsen I, Alexandersen P, Bihlet A, Andersen JR, Riis BJ, Bay-Jensen AC, Christiansen C; CSMC021C2301/2 investigators.

Osteoarthritis Cartilage. 2015 Apr;23(4):532-43. doi: 10.1016/j.joca.2014.12.019. Epub 2015 Jan 9.

6.

Nasal salmon calcitonin blunts bone microstructure alterations in healthy postmenopausal women.

Rizzoli R, Sigaud A, Azria M, Herrmann FR.

Osteoporos Int. 2015 Jan;26(1):383-93. doi: 10.1007/s00198-014-2937-5. Epub 2014 Oct 22.

PMID:
25566730
7.

Salmon calcitonin in the treatment of elderly women with type 2 diabetes complicated with osteoporosis.

Dexue L, Yueyue Z.

Pak J Pharm Sci. 2014 Nov;27(6 Suppl):2079-81.

PMID:
25410076
8.

Strategic approaches for enhancement of in vivo transbuccal peptide drug delivery in rabbits using iontophoresis and chemical enhancers.

Oh DH, Kim MJ, Jeon SO, Seo JE, Jeong SH, Kang JW, Choi YW, Lee S.

Pharm Res. 2015 Mar;32(3):929-40. doi: 10.1007/s11095-014-1507-z. Epub 2014 Sep 18.

PMID:
25231009
9.

Efficacy and safety of oral recombinant calcitonin tablets in postmenopausal women with low bone mass and increased fracture risk: a randomized, placebo-controlled trial.

Binkley N, Bone H, Gilligan JP, Krause DS.

Osteoporos Int. 2014 Nov;25(11):2649-56. doi: 10.1007/s00198-014-2796-0. Epub 2014 Jul 16.

10.

Salmon calcitonin use and associated cancer risk.

Overman RA, Borse M, Gourlay ML.

Ann Pharmacother. 2013 Dec;47(12):1675-84. doi: 10.1177/1060028013509233. Epub 2013 Oct 25. Review.

PMID:
24259626
11.

In brief: cancer risk with salmon calcitonin.

[No authors listed]

Med Lett Drugs Ther. 2013 Apr 15;55(1414):29. No abstract available.

PMID:
23588101
12.

Experts recommend against calcitonin-salmon for postmenopausal osteoporosis.

Traynor K.

Am J Health Syst Pharm. 2013 Apr 15;70(8):648, 650. doi: 10.2146/news130028. No abstract available.

PMID:
23552038
13.

Low cytotoxic elastic niosomes loaded with salmon calcitonin on human skin fibroblasts.

Manosroi A, Chankhampan C, Ofoghi H, Manosroi W, Manosroi J.

Hum Exp Toxicol. 2013 Jan;32(1):31-44. doi: 10.1177/0960327112454892. Epub 2012 Oct 30.

PMID:
23111885
14.

Orally delivered salmon calcitonin-loaded solid lipid nanoparticles prepared by micelle-double emulsion method via the combined use of different solid lipids.

Chen C, Fan T, Jin Y, Zhou Z, Yang Y, Zhu X, Zhang ZR, Zhang Q, Huang Y.

Nanomedicine (Lond). 2013 Jul;8(7):1085-100. doi: 10.2217/nnm.12.141. Epub 2012 Oct 17.

PMID:
23075315
15.

A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: the Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) trial.

Binkley N, Bolognese M, Sidorowicz-Bialynicka A, Vally T, Trout R, Miller C, Buben CE, Gilligan JP, Krause DS; Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) Investigators.

J Bone Miner Res. 2012 Aug;27(8):1821-9. doi: 10.1002/jbmr.1602.

16.

Calcitonin for acute neuropathic pain associated with spinal cord injury.

Humble SR.

Anaesth Intensive Care. 2011 Jul;39(4):682-6.

17.

Efficacy and harms of nasal calcitonin in improving bone density in young patients with inflammatory bowel disease: a randomized, placebo-controlled, double-blind trial.

Pappa HM, Saslowsky TM, Filip-Dhima R, DiFabio D, Hassani Lahsinoui H, Akkad A, Grand RJ, Gordon CM.

Am J Gastroenterol. 2011 Aug;106(8):1527-43. doi: 10.1038/ajg.2011.129. Epub 2011 Apr 26.

18.

Application of the yeast-surface-display system for orally administered salmon calcitonin and safety assessment.

Sun PN, Zhang XC, Chen YS, Zang XN.

Biotechnol Prog. 2010 Jul-Aug;26(4):968-74. doi: 10.1002/btpr.413.

PMID:
20730756
19.

Nanoparticles of glycol chitosan and its thiolated derivative significantly improved the pulmonary delivery of calcitonin.

Makhlof A, Werle M, Tozuka Y, Takeuchi H.

Int J Pharm. 2010 Sep 15;397(1-2):92-5. doi: 10.1016/j.ijpharm.2010.07.001. Epub 2010 Jul 7.

PMID:
20619330
20.

Conjugation of salmon calcitonin to a combed-shaped end functionalized poly(poly(ethylene glycol) methyl ether methacrylate) yields a bioactive stable conjugate.

Ryan SM, Wang X, Mantovani G, Sayers CT, Haddleton DM, Brayden DJ.

J Control Release. 2009 Apr 2;135(1):51-9. doi: 10.1016/j.jconrel.2008.12.014. Epub 2009 Jan 8.

PMID:
19168100

Supplemental Content

Loading ...
Support Center